Eledon Pharmaceuticals, Inc. - Common Stock (ELDN)
4.5200
-0.1800 (-3.83%)
Eledon Pharmaceuticals is a biopharmaceutical company focused on developing innovative therapies for the treatment of serious diseases through advancing the understanding of the immune system
The company is primarily engaged in creating and commercializing novel therapeutics that aim to enhance immune responses, with a strong emphasis on addressing unmet medical needs in areas such as neuromuscular and autoimmune disorders. By leveraging its proprietary platform, Eledon seeks to provide groundbreaking solutions that improve patient outcomes and transform healthcare in the specialties it targets.
Frequently Asked Questions
Is Eledon Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Eledon Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Eledon Pharmaceuticals, Inc. - Common Stock trade on?
Eledon Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Eledon Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Eledon Pharmaceuticals, Inc. - Common Stock is ELDN on the Nasdaq Stock Market
What is the current price of Eledon Pharmaceuticals, Inc. - Common Stock?
The current price of Eledon Pharmaceuticals, Inc. - Common Stock is 4.520
When was Eledon Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of Eledon Pharmaceuticals, Inc. - Common Stock was at 4:00 pm EST on February 10th, 2025
What is the market capitalization of Eledon Pharmaceuticals, Inc. - Common Stock?
The market capitalization of Eledon Pharmaceuticals, Inc. - Common Stock is 101.73M
How many shares of Eledon Pharmaceuticals, Inc. - Common Stock are outstanding?
Eledon Pharmaceuticals, Inc. - Common Stock has 22.51M shares outstanding.